CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831971007
- Phone
- 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- POSASR Other POSASR
- S-3ASR Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-1MEF Other S-1MEF
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B/A Other Registration Statement
- 8-A12B Other Registration of Securities
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 8 of 8 · 154 filings